Abstract
Cystic fibrosis (CF) causes infertility and subfertility due to various factors, including altered cervical mucus, delayed puberty, and hormonal imbalances. With the introduction of the CFTR modulator therapy elexacaftor-tezacaftor-ivacaftor, we have observed an increase in unplanned pregnancies among women undergoing ETI treatment in our CF center, despite repeated recommendations for strict fertility monitoring. It appears that these pregnancies are more likely attributed to reduced attention to the possibility of conception rather than contraceptive failure. The perception of subfertility developed by women with CF over time, before the era of modulators, can influence their long-term habits and lead to the underuse of contraceptive methods. While further research is needed to fully understand the effects of ETI on fertility, healthcare providers should be attentive to the fertility concerns of women with CF, particularly those treated with modulators in adulthood.
Data availability
Since these are very confidential personal data, it is not applicable.
References
Hughan KS, Daley T, Rayas MS, Kelly A, Roe A (2019) Female reproductive health in cystic fibrosis. J Cyst Fibros. https://doi.org/10.1016/j.jcf.2019.08.024
Shteinberg M, Lulu AB, Downey DG, Blumenfeld Z, Rousset-Jablonski C, Perceval M, Colombo A, Stein N, Livnat G, Gur M, Bentur L, Mussaffi H, Blau H, Sarouk I, Dagan A, Kerem E, Aviram M, Picard E, Aliberti S, Álvarez A, Miranda JP, Polverino E, Durieu I, Stuart Elborn J, Cohen-Cymberknoh M (2018) Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age. J Cyst Fibros 18(4):525–529. https://doi.org/10.1016/j.jcf.2018.10.009
Goldsweig B, Kaminski B, Sidhaye A, Blackman SM, Kelly A (2019) Puberty in cystic fibrosis. J Cyst Fibros. https://doi.org/10.1016/j.jcf.2019.08.013
Schram CA, Stephenson AL, Hannam TG, Tullis E (2015) Cystic fibrosis and ovarian reserve: a cross-sectional study examining serum anti-mullerian hormone (amh) in young women. J Cyst Fibros 14(3):398–402. https://doi.org/10.1016/j.jcf.2014.09.008
Bower JK, Volkova N, Ahluwalia N, Sahota G, Xuan F, Chin A, Weinstock TG, Ostrenga J, Elbert A (2023) Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study. J Cyst Fibros. https://doi.org/10.1016/j.jcf.2023.03.002
Roe AH, Traxler S, Schreiber CA (2016) Contraception in women with cystic fibrosis: a systematic review of the literature. Contraception. https://doi.org/10.1016/j.contraception.2015.07.007
Jain R, Taylor-Cousar JL (2021) Fertility, pregnancy and lactation considerations for women with CF in the CFTR modulator Era. J Pers Med 11(5):418. https://doi.org/10.3390/jpm11050418
Shteinberg M, Taylor-Cousar JL, Durieu I, Cohen-Cymberknoh M (2021) Fertility and pregnancy in cystic fibrosis. Chest 160(6):2051–2060. https://doi.org/10.1016/j.chest.2021.07.024
Nash EF, Middleton PG, Taylor-Cousar JL (2020) Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators - an international survey. J Cyst Fibros 19(4):521–526. https://doi.org/10.1016/j.jcf.2020.02.018
O’Connor KE, Goodwin DL, NeSmith A, Garcia B, Mingora C, Ladores SL, Rowe SM, Krick S, Solomon GM (2021) Elexacafator/tezacaftor/ivacaftor resolves subfertility in females with CF: a two center case series. J Cyst Fibros. https://doi.org/10.1016/j.jcf.2020.12.011
Peng G, Taylor-Cousar JL, Lee M, Keller A, West NE, Kazmerski TM, Goralski JL, Aitken ML, Roe AH, Hadjiliadis D, Uluer A, Flume PA, Mody S, Bray LA, Jain R (2023) Association between unplanned pregnancies and maternal exacerbations in cystic fibrosis. J Cyst Fibros. https://doi.org/10.1016/j.jcf.2023.03.020
Funding
This research received no financial support. The content of this article is solely the responsibility of the authors.
Author information
Authors and Affiliations
Contributions
Conceptualization: VD; Methodology: VD; Writing—original draft preparation: VD; Writing—review and editing: VD, GA, AG, FAB, LT; Supervision: VD.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Daccò, V., Alicandro, G., Trespidi, L. et al. Unplanned pregnancies following the introduction of elexacaftor/tezacaftor/ivacaftor therapy in women with cystic fibrosis. Arch Gynecol Obstet 308, 1657–1659 (2023). https://doi.org/10.1007/s00404-023-07153-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-023-07153-y